2021 annual financial data
Ovid Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was 56.92%.
Operating income was 124,209,092 USD and net income was 122,834,584 USD.
Operating cash flow was 118,611,673 USD.
Get free Ovid Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 208,382,779 USD
- Operating income
- 124,209,092 USD
- Net income
- 122,834,584 USD
- Operating cash flow
- 118,611,673 USD